Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P F Searle

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Gene Therapy|April 1, 2005
Inhibition of NF-kappaB enhances the cytotoxicity of virus-directed enzyme prodrug therapy and oncolytic adenovirus cancer gene therapyD H Palmer, M-J Chen, P F Searle, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|August 25, 2001
Gene therapy for colorectal cancer: therapeutic potentialM J Chen, G A Chung-Faye, P F Searle, et al.
Molecular and Cellular Biology|July 1, 1984
Regulation, linkage, and sequence of mouse metallothionein I and II genesP F Searle, B L Davison, G W Stuart, et al.
Prostate Cancer and Prostatic Diseases|August 30, 2007
Combining gene and immunotherapy for prostate cancerJ G Young, N K Green, V Mautner, et al.
Anti-Cancer Drug Design|June 2, 2000
Virus-directed enzyme prodrug therapy using CB1954J I Grove, P F Searle, S J Weedon, et al.
International Immunology|May 1, 1993
MHC class II-restricted presentation of endogenously synthesized antigen: Epstein-Barr virus transformed B cell lines can present the viral glycoprotein gp340 by two distinct pathwaysS P Lee, L E Wallace, M Mackett, et al.
Gene Therapy|April 21, 2001
Tumour-specific therapeutic adenovirus vectors: repression of transgene expression in healthy cells by endogenous p53K S Lipinski, A H Djeha, E Krausz, et al.
Cancer Gene Therapy|June 1, 2000
Expression of Escherichia coli B nitroreductase in established human tumor xenografts in mice results in potent antitumoral and bystander effects upon systemic administration of the prodrug CB1954A H Djeha, A Hulme, M T Dexter, et al.
Gene Therapy|November 13, 2001
In vivo gene therapy for colon cancer using adenovirus-mediated, transfer of the fusion gene cytosine deaminase and uracil phosphoribosyltransferaseG A Chung-Faye, M J Chen, N K Green, et al.
Nucleic Acids Research|October 11, 1990
Expression of a human O6-alkylguanine-DNA-alkyltransferase cDNA in human cells and transgenic miceC Y Fan, P M Potter, J Rafferty, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Gene Therapy|April 1, 2005
Inhibition of NF-kappaB enhances the cytotoxicity of virus-directed enzyme prodrug therapy and oncolytic adenovirus cancer gene therapyD H Palmer, M-J Chen, P F Searle, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|August 25, 2001
Gene therapy for colorectal cancer: therapeutic potentialM J Chen, G A Chung-Faye, P F Searle, et al.
Molecular and Cellular Biology|July 1, 1984
Regulation, linkage, and sequence of mouse metallothionein I and II genesP F Searle, B L Davison, G W Stuart, et al.
Prostate Cancer and Prostatic Diseases|August 30, 2007
Combining gene and immunotherapy for prostate cancerJ G Young, N K Green, V Mautner, et al.
Anti-Cancer Drug Design|June 2, 2000
Virus-directed enzyme prodrug therapy using CB1954J I Grove, P F Searle, S J Weedon, et al.
International Immunology|May 1, 1993
MHC class II-restricted presentation of endogenously synthesized antigen: Epstein-Barr virus transformed B cell lines can present the viral glycoprotein gp340 by two distinct pathwaysS P Lee, L E Wallace, M Mackett, et al.
Gene Therapy|April 21, 2001
Tumour-specific therapeutic adenovirus vectors: repression of transgene expression in healthy cells by endogenous p53K S Lipinski, A H Djeha, E Krausz, et al.
Cancer Gene Therapy|June 1, 2000
Expression of Escherichia coli B nitroreductase in established human tumor xenografts in mice results in potent antitumoral and bystander effects upon systemic administration of the prodrug CB1954A H Djeha, A Hulme, M T Dexter, et al.
Gene Therapy|November 13, 2001
In vivo gene therapy for colon cancer using adenovirus-mediated, transfer of the fusion gene cytosine deaminase and uracil phosphoribosyltransferaseG A Chung-Faye, M J Chen, N K Green, et al.
Nucleic Acids Research|October 11, 1990
Expression of a human O6-alkylguanine-DNA-alkyltransferase cDNA in human cells and transgenic miceC Y Fan, P M Potter, J Rafferty, et al.
Pageof 4